Early diagnosis of prostate cancer (PCa), the second most common cancer worldwide, is based on digital rectal examination and the determination of prostate-specific antigen (PSA) blood levels, followed by transrectal biopsy, an invasive procedure with potential side effects, mainly infections and haemorrhage (Ferlay et al, 2004). Here, KLK3 is linked to Familial prostate cancer.